Building laboratory testing capacity
Position Statement
Diabetes Care2018;42(Suppl. 1):S1–S194.
The new guidelines provide public health guidance on pharmacological agents for managing hyperglycaemia in type 1 and type 2 diabetes for use in primary health-care in low-resource settings. These guidelines update the recommendations for managing hyperglycaemia in the WHO Package of Essential NCD I...nterventions (WHO PEN) for primary care in low-resources settings, reviewing several newer oral agents as second- and third-line treatment: dipeptidyl peptidase-4 inhibitors, sodium-glucose co-transporter 2 inhibitors and thiazolidinediones. The guidelines also present recommendations on the selection of type of insulin (analogue versus human insulin) for adults with type 1 and type 2 diabetes.
more
WHO Package of Essential NCD Interventions (PEN)
Accessed March 18,2019
In this report, potential reasons for this apparent
contradiction between cherished human values
and observed social actions are explored with a
view to better formulating concrete steps that
governments and other stakeholders can take to
reshape social attitudes and public policy.
Assessment of the quality of institutional care for adults with psychosocial and intellectual disabilities in the WHO European Region.
The specific objectives of the project were to address gaps in knowledge about the number and characteristics of such long-term institutions and to identify deficie...ncies in current care standards through the lens of the United Nations Convention on the Rights of Persons with Disabilities. This publication examines and rates the quality of care and protection of human rights in selected institutions in over 20 countries in the Region using the WHO QualityRights toolkit. It identifies steps to take to continue progress toward deinstitutionalization and to ensure respect for the rights of people with psychosocial and intellectual disabilities.
more
Reduced healthy life expectancy due to the high burden of both mental ill health and noncommunicable diseases (NCDs) is a major public health concern in the European Region. The links between mental disorders and major NCDs are well established.
In clinical practice, however, mental disorders in pa...tients with NCDs as well as NCDs in patients with mental disorders are often overlooked. Premature mortality and disability could be reduced if there were a greater focus on comorbidity.
This report addresses the needs of adults of working age with mental health problems – those with common mental disorders such as depression and anxiety and those with more severe conditions such as schizophrenia and bi-polar affective disorder. It also addresses the needs of those with NCDs, specifically cardiovascular diseases, cancers, chronic respiratory diseases and diabetes mellitus.
more
Addressing comorbidity between mental disorders and major noncommunicable diseases (Russian Version)
Mental disorders are one of the top public health challenges in the WHO European Region, affecting about 25% of the population every year. In all countries, mental health problems are much more prevalent among the people who are most deprived. The WHO European Region therefore faces diverse challeng...es affecting both the mental well-being of the population and the provision and quality of care for people with mental health problems.
The European Mental Health Action Plan focuses on seven interlinked objectives and proposes effective action to strengthen mental health and well-being. Investing in mental health is essential for the sustainability of health and socioeconomic policies in the European Region. The Action Plan corresponds to the four priority areas of the European policy framework for health and wellbeing, Health 2020, and will contribute directly to its implementation.
more
SADF POLICY BRIEF
31 October 2018 Issue n° 8
ISSN: 2406-5625
Manual for use in primary care
Alcohol, medication, tobacco, illegal drugs, addictive behaviour
Second, revised edition with new layout
Juni 2014
Update of the Mental Health Gap Action Programme
(mhGAP) Guideline for Mental, Neurological and Substance use Disorders May 2015
Overview
Learning objectives
• Promote respect and dignity for people with other significant mental health complaints.
• Know the common presentation of other significant mental health complaints.
• Know the assessment principles of other significant mental health complaints.
• Know the... management principles of other significant mental health complaints.
• Perform an assessment for other significant mental health complaints.
• Use effective communication skills in interaction with people with other significant
mental health complaints.
• Assess and manage physical health in other significant mental health complaints.
• Provide psychosocial interventions to persons with other significant mental health
complaints and their carers.
• Know there are no specific pharmacological interventions for other significant mental
health complaints.
• Plan and perform follow-up for other significant mental health complaints.
• Refer to specialists and links with outside services for other significant mental health
complaints where appropriate and available.
more
Overview
Learning objectives
• Promote respect and dignity for people with psychoses.
• Name common presentations of psychoses.
• Name assessment principles of psychoses.
• Name management principles of psychoses.
• Perform an assessment for psychoses.
• Use effective communicatio...n skills when interacting with a person psychoses.
• Assess and manage physical health concerns in psychoses.
• Assess and manage emergency presentations of psychoses.
• Provide psychosocial interventions to persons with psychoses and their carers.
• Deliver pharmacological interventions as needed and appropriate in psychoses
considering special populations.
• Plan and performs follow-up sessions for people with psychoses.
• Refer to specialist and links with outside agencies for psychoses as appropriate and
available.
more
World Drug Report 2018
-5-